152 related articles for article (PubMed ID: 36509632)
21. The Prevalence of
Saha J; Panja A; Nayek K
Hemoglobin; 2021 May; 45(3):157-162. PubMed ID: 34060430
[TBL] [Abstract][Full Text] [Related]
22. A risk score for predicting pulmonary hypertension in patients with non-transfusion-dependent thalassemia in northeastern Thailand: The E-SAAN score.
Teawtrakul N; Pussadhamma B; Ungprasert P; Prayalaw P; Fucharoen S; Jetsrisuparb A; Pongudom S; Sirijerachai C; Chansung K; Wanitpongpun C; Thongbuaban S; Thinkhamrop B; Chuncharunee S
Hematology; 2015 Aug; 20(7):416-21. PubMed ID: 25386747
[TBL] [Abstract][Full Text] [Related]
23. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
[TBL] [Abstract][Full Text] [Related]
24. Marital status and paternity in patients with Transfusion- Dependent Thalassemia (TDT) and Non Transfusion-Dependent Thalassemia (NTDT): an ICET - A survey in different countries.
De Sanctis V; Soliman AT; El-Hakim I; Christou S; Mariannis D; Karimi M; Ladis V; Kattamis A; Daar S; Yassin M; Canatan D; Galati MC; Raiola G; Campisi S; Kakkar S; Kaleva V; Saki F; Ellinides A; Pikis G; Christodoulides C; Abdulla M; Di Maio S; Theodoridis C; Elsedfy H; Kattamis C
Acta Biomed; 2019 Sep; 90(3):225-237. PubMed ID: 31580308
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary hypertension in non-transfusion-dependent thalassemia: Correlation with clinical parameters, liver iron concentration, and non-transferrin-bound iron.
Inthawong K; Charoenkwan P; Silvilairat S; Tantiworawit A; Phrommintikul A; Choeyprasert W; Natesirinilkul R; Siwasomboon C; Visrutaratna P; Srichairatanakool S; Chattipakorn N; Sanguansermsri T
Hematology; 2015 Dec; 20(10):610-7. PubMed ID: 25964094
[TBL] [Abstract][Full Text] [Related]
26. Risks of red blood cell alloimmunization in transfusion-dependent β-thalassemia in Oman: a 25-year experience of a university tertiary care reference center and a literature review.
Al-Riyami AZ; Al-Muqbali A; Al-Sudiri S; Murthi Panchatcharam S; Zacharia M; Al-Mahrooqi S; Al-Hosni S; Al-Marhoobi A; Daar S
Transfusion; 2018 Apr; 58(4):871-878. PubMed ID: 29399805
[TBL] [Abstract][Full Text] [Related]
27. Comparison of a transfusion preparation of newly formed red cells and standard washed red cell transfusions in patients with homozygous beta-thalassemia.
Collins AF; Gonçalves-Dias C; Haddad S; Talbot R; Herst R; Tyler BJ; Zuber E; Blanchette VS; Olivieri NF
Transfusion; 1994 Jun; 34(6):517-20. PubMed ID: 8023393
[TBL] [Abstract][Full Text] [Related]
28. Is splenectomy for massive splenomegaly safe in children?
Al-Salem AH
Am J Surg; 1999 Jul; 178(1):42-5. PubMed ID: 10456701
[TBL] [Abstract][Full Text] [Related]
29. Clinical manifestation of beta-thalassemia/hemoglobin E disease.
Fucharoen S; Ketvichit P; Pootrakul P; Siritanaratkul N; Piankijagum A; Wasi P
J Pediatr Hematol Oncol; 2000; 22(6):552-7. PubMed ID: 11132229
[TBL] [Abstract][Full Text] [Related]
30. Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients.
Yavarian M; Karimi M; Bakker E; Harteveld CL; Giordano PC
Haematologica; 2004 Oct; 89(10):1172-8. PubMed ID: 15477200
[TBL] [Abstract][Full Text] [Related]
31. Epidemiologic study of major complications in adolescent and adult patients with thalassemia in Northeastern Thailand: the E-SAAN study phase I.
Teawtrakul N; Jetsrisuparb A; Pongudom S; Sirijerachai C; Chansung K; Wanitpongpun C; Fucharoen S
Hematology; 2018 Jan; 23(1):55-60. PubMed ID: 28759343
[TBL] [Abstract][Full Text] [Related]
32. Hypothyroidism in children with Hb E/β-thalassemia compared between those who received regular transfusion and those who underwent hematopoietic stem cell transplantation.
Sriwichakorn C; Nakavachara P; Jitpirasakun S; Pooliam J; Sanpakit K
Pediatr Hematol Oncol; 2023 Feb; 40(1):1-13. PubMed ID: 35499955
[TBL] [Abstract][Full Text] [Related]
33. Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia.
Thompson AA; Walters MC; Kwiatkowski J; Rasko JEJ; Ribeil JA; Hongeng S; Magrin E; Schiller GJ; Payen E; Semeraro M; Moshous D; Lefrere F; Puy H; Bourget P; Magnani A; Caccavelli L; Diana JS; Suarez F; Monpoux F; Brousse V; Poirot C; Brouzes C; Meritet JF; Pondarré C; Beuzard Y; Chrétien S; Lefebvre T; Teachey DT; Anurathapan U; Ho PJ; von Kalle C; Kletzel M; Vichinsky E; Soni S; Veres G; Negre O; Ross RW; Davidson D; Petrusich A; Sandler L; Asmal M; Hermine O; De Montalembert M; Hacein-Bey-Abina S; Blanche S; Leboulch P; Cavazzana M
N Engl J Med; 2018 Apr; 378(16):1479-1493. PubMed ID: 29669226
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular effects of splenomegaly and splenectomy in beta-thalassemia.
Aessopos A; Farmakis D; Deftereos S; Tsironi M; Polonifi A; Moyssakis I; Diamanti-Kandaraki E; Papalambros E
Ann Hematol; 2005 Jun; 84(6):353-7. PubMed ID: 15711802
[TBL] [Abstract][Full Text] [Related]
35. Severe bacterial infections in patients with non-transfusion-dependent thalassemia: prevalence and clinical risk factors.
Teawtrakul N; Jetsrisuparb A; Sirijerachai C; Chansung K; Wanitpongpun C
Int J Infect Dis; 2015 Oct; 39():53-6. PubMed ID: 26358855
[TBL] [Abstract][Full Text] [Related]
36. A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.
Cappellini MD; Viprakasit V; Taher AT; Georgiev P; Kuo KHM; Coates T; Voskaridou E; Liew HK; Pazgal-Kobrowski I; Forni GL; Perrotta S; Khelif A; Lal A; Kattamis A; Vlachaki E; Origa R; Aydinok Y; Bejaoui M; Ho PJ; Chew LP; Bee PC; Lim SM; Lu MY; Tantiworawit A; Ganeva P; Gercheva L; Shah F; Neufeld EJ; Thompson A; Laadem A; Shetty JK; Zou J; Zhang J; Miteva D; Zinger T; Linde PG; Sherman ML; Hermine O; Porter J; Piga A;
N Engl J Med; 2020 Mar; 382(13):1219-1231. PubMed ID: 32212518
[TBL] [Abstract][Full Text] [Related]
37. Elevated levels of platelet- and red cell-derived extracellular vesicles in transfusion-dependent β-thalassemia/HbE patients with pulmonary arterial hypertension.
Manakeng K; Prasertphol P; Phongpao K; Chuncharunee S; Tanyong D; Worawichawong S; Svasti S; Chaichompoo P
Ann Hematol; 2019 Feb; 98(2):281-288. PubMed ID: 30334069
[TBL] [Abstract][Full Text] [Related]
38. Thalidomide for Patients with β-Thalassemia: A Multicenter Experience.
Yang K; Wu Y; Zhou Y; Long B; Lu Q; Zhou T; Wang L; Geng Z; Yin X
Mediterr J Hematol Infect Dis; 2020; 12(1):e2020021. PubMed ID: 32395210
[TBL] [Abstract][Full Text] [Related]
39. Partial dearterialization of the spleen in thalassemia major.
Banani SA
J Pediatr Surg; 1998 Mar; 33(3):449-53. PubMed ID: 9537555
[TBL] [Abstract][Full Text] [Related]
40. Splenectomy for people with thalassaemia major or intermedia.
Easow Mathew M; Sharma A; Aravindakshan R
Cochrane Database Syst Rev; 2016 Jun; (6):CD010517. PubMed ID: 27296775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
